Based on the SMILES Nc1ccn([C@@H]2CO[C@H](CO)O2)c(=O)n1, the molecule has a drug half life time in humans after IV administration of 82.000 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one